High prevalence of the G101W germline mutation in the CDKN2A (p16INK4a) gene in 62 Italian malignant melanoma families

American Journal of Medical Genetics

Volumn 107, Issue 3, 2002, Pages 214-221

  Bianchi Scarrà, Giovanna ^a   Goldstein, Alisa M ^a   Rainero, Maria Luisa ^a   Padovani, Laura ^a   Pastorino, Lorenza ^a   Lantieri, Francesca ^a   Ghiorzo, Paola ^a   Ciotti, Paola ^a   Barile, Monica ^a   Mantelli, Michela ^a  

^a UNIVERSITY OF GENOA   (Italy)

Author keywords

CDKN2A; Families; G101W; Italian; Melanoma; Mutation

Indexed keywords

PROTEIN P16;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER GENETICS; CDKN2A GENE; DNA DETERMINATION; FAMILY; GENE; GENE MUTATION; GENETIC SCREENING; GENETIC SUSCEPTIBILITY; GERM LINE; HUMAN; ITALY; MAJOR CLINICAL STUDY; MELANOMA; PANCREAS CANCER; PATIENT COUNSELING; PREVALENCE; PRIORITY JOURNAL; RELATIVE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALLELES; AMINO ACID SUBSTITUTION; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DNA MUTATIONAL ANALYSIS; DNA, NEOPLASM; FAMILY HEALTH; FEMALE; GENE FREQUENCY; GENOTYPE; GERM-LINE MUTATION; HUMANS; ITALY; MALE; MELANOMA; MIDDLE AGED; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; PROMOTER REGIONS (GENETICS);

EID: 18244408287     PISSN: 01487299     EISSN: None     Source Type: Journal    
DOI: 10.1002/ajmg.10137     Document Type: Article

References (42)

1. CDKN2A variants in a population-based sample of Queensland families with melanoma
2. Sporadic multiple primary melanoma cases: CDKNZA germline mutations with a founder effect
3. Novel germline p16 mutation in familial malignant melanoma in southern Sweden
4. High frequency of multiple melanomas and breast and pancreas carcinomas in CDKN2A mutation-positive melanoma families
5. Penetrance and expressivity of the chromosome 9p by melanoma susceptibility locus (MLM)
6. Familial melanoma and pancreatic cancer
7. A single genetic origin for the G101W CDKN2A mutation in 20 melanoma-prone families
8. CDKN2A/p16(INK4a) mutations and lack of p19ARF involvement in familial melanoma kindreds
9. Prevalence of germ-line mutations in p16, p19ARF, and CDK4 in familial melanoma: Analysis of a clinic-based population
10. Analysis of the CDKN2A, CDKN2B and CDK4 genes in 48 Australian melanoma kindreds
11. Characterization of Ligurian melanoma families and risk of occurrence of other neoplasia
12. Screening for CDKN2A mutations in hereditary melanoma
13. Increased risk of pancreatic cancer in melanoma-prone kindreds with p16INK4A mutations
14. Sun-related risk factors in melanoma-prone families with CDKN2A mutations
15. Genotype-phenotype relationships in U.S. melanoma-prone families with CDKN2A and CDK4 mutations
16. The genetics of hereditary melanoma and nevi. 1998 update
17. Homozygotes for CDKN2 (p16) germline mutation in Dutch familial melanoma kindreds
18. Familial melanoma; CDKN2A and beyond
19. Germline mutations of the CDKN2 gene in UK melanoma families
20. Mutation screening of the CDKN2A promoter in melanoma families
21. Analysis of the p16 gene, CDKN2, in 17 Australian melanoma kindreds
22. INK4a) and CDK4 mutation analysis in 131 Australian melanoma probands: Effect of family history and multiple primary melanomas
23. Germline p16 mutations in familial melanoma
24. Incidence of malignant melanoma in Auckland, New Zealand: Highest rates in the world
25. Analysis of the p16 gene (CDKN2) as a candidate for the chromosome 9p21 melanoma susceptibility locus
26. Counseling and DNA testing for individuals perceived to be genetically predisposed to melanoma: A consensus statement of the melanoma genetics consortium
27. Mutation of the CDKN2A 5′ UTR creates an aberrant initiation codon and predisposes to melanoma
28. CDKN2A germline mutations in U.K. patients with familial melanoma and multiple primary melanomas
29. CDKN2A mutations in multiple primary melanomas
30. Hutation testing in melanoma families: INK4A, CDK4, and INK4D
31. Clinical cancer genetics and risk counseling
32. Mutations and altered expression of p16INK4 in human cancer
33. Genetics and the origin of European languages
34. Screening of germline mutations in the CDKN2A and CDKN2B genes in Swedish families with hereditary cutaneous melanoma
35. Mutations associated with familial melanoma impair p16INK4A function
36. CDKN2A mutations in Spanish cutaneous malignant melanoma families and patients with multiple melanomas and other neoplasia
37. Prevalence of p16 and CDK4 germline mutations in 48 melanoma-prone families in France
38. Functional reassessment of P16 variants using a transfection-based assay
39. A familial syndrome of pancreatic cancer and melanoma with a mutation in the CDKN2 tumour-suppressor gene
40. Germline mutations in the p16INK4a binding domain of CDK4 in familial melanoma